Imatinib Mesylate in Treating Patients With Metastatic Breast Cancer

Clinical trial NCT00045188 · COMPLETED

Trial details

NCT number: NCT00045188
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Male Breast Cancer Recurrent Breast Cancer Stage IV Breast Cancer

Start date: 2002-08-01
Primary completion: 2004-07-01
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.